Companies: 10,795·Total market cap: $144.5T
Ayala Pharmaceuticals, Inc.

Ayala Pharmaceuticals, Inc.

ADXSOTCHealthcare
$0.60
+$0.00(+0.00%)
Market Cap$25707577
P/E Ratio—
52W High$0.801
52W Low$0.0011
Overview

Ayala Pharmaceuticals, Inc. (ADXS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001100397 · ADXS · OTC · as of Jun 15, 2026

Filing snapshot

1,000+
Total Filings
SCHEDULE 13G
Latest Form
2025-04-16
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001100397 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2024-04-26
Fiscal Year End
Apr 26, 2024
Accession No.
0001493152-24-016714
Primary Document
form10-ka.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001100397 · Accession 0001493152-24-016714

Latest Key Filings

10-QQuarterly Report
Quarterly Report
2023-11-20
View 10-Q on SEC
8-KCurrent Report
Current Report
2024-04-19Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-04-16
View
15-12G15-12G
15-12G
2024-05-09
View
10-K/AAnnual Report (Amended)
Annual Report (Amended)
2024-04-26
View
8-K/ACurrent Report (Amended)
Current Report (Amended)
2024-04-19
View
10-KAnnual Report
Annual Report
2024-04-16
View
S-8 POSS-8 POS
S-8 POS
2024-04-15
View
S-8 POSS-8 POS
S-8 POS
2024-04-15
View
S-8 POSS-8 POS
S-8 POS
2024-04-15
View
S-8 POSS-8 POS
S-8 POS
2024-04-15
View
S-8 POSS-8 POS
S-8 POS
2024-04-15
View
S-8 POSS-8 POS
S-8 POS
2024-04-15
View
S-8 POSS-8 POS
S-8 POS
2024-04-15
View
S-8 POSS-8 POS
S-8 POS
2024-04-15
View
S-8 POSS-8 POS
S-8 POS
2024-04-15
View
8-KCurrent Report
Current Report
2024-04-03
View
Showing 1–15 of 609 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001100397  |  Exchange: OTC · Healthcare

Ayala Pharmaceuticals, Inc. (OTC: ADXS) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001100397, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Ayala Pharmaceuticals, Inc.'s most comprehensive regulatory disclosure. The most recent Ayala Pharmaceuticals, Inc. 10-K was filed on 2024-04-26 for fiscal year ending 2024. Historical ADXS 10-K annual reports are available from 2011 through 2024.

Investors researching Ayala Pharmaceuticals, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-15
Related Companies SEC Filings — Healthcare
IBOGF SEC Filings →AAGH SEC Filings →HESG SEC Filings →APLIF SEC Filings →AGNPF SEC Filings →NMLSF SEC Filings →AGTX SEC Filings →VGLS SEC Filings →
→ ADXS Financials→ ADXS Earnings→ ADXS Insider Trades

Frequently Asked Questions

ADXS SEC Filings · 8 questions

Ayala Pharmaceuticals, Inc. (ADXS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. Ayala Pharmaceuticals, Inc.'s CIK is 0001100397.

ADXS SEC filingsAyala Pharmaceuticals, Inc. SEC documentsfind ADXS 10-K